(Q35608207)

9 August 2017

1 reference

title

Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know (English)

1 reference

stem cell transplantation

9 August 2017

main subject

1 reference

Leather HL

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Bone Marrow Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

33

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

137-152

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704316

9 August 2017

exact match

0 references

cites work

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Role of cytochromes P450 in drug metabolism and hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Mechanisms of clinically relevant drug interactions associated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Coadministration of itraconazole and tacrolimus after thoracic organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Interaction between tacrolimus and chloramphenicol in a renal transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Renal allograft dysfunction associated with rifampin-tacrolimus interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Interaction of fluconazole and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Absence of significant interaction of fluconazole with cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Cyclosporine and itraconazole interaction in heart and lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Does ciprofloxacin interact with cyclosporine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

The mechanism of cyclosporine toxicity induced by clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Interaction between quinupristin/dalfopristin and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Recent advances: the cytochrome P450 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Fluconazole-induced symptomatic phenytoin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Fluconazole and phenytoin: a predictable interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Potentiation of action of warfarin by itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Torsades de pointes after terfenadine-itraconazole interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Itraconazole-induced rhabdomyolysis and acute renal failure in a heart transplant recipient treated with simvastatin and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Modulation of irinotecan metabolism by ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

21 January 2018

Food-drug interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Drug-grapefruit juice interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Interaction between grapefruit juice and midazolam in humans*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Amlodipine and grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

The clinical and economic potential of cyclosporin drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Survey of alternative medicine use among organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Effects of St. John's wort on irinotecan metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

INTERACTION OF FLUCONAZOLE WITH CYCLOSPORIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Diltiazem increases tacrolimus concentrations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction between tacrolimus and erythromycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction between FK506 and erythromycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction between tacrolimus and erythromycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Use of phenobarbital in the management of acute tacrolimus toxicity: a case report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Tacrolimus-phenytoin interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction between theophylline and tacrolimus in a renal transplant patient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Drug interactions with fluconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction of fluconazole with cyclosporin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Fluconazole-cyclosporine interaction: a dose-dependent effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction between cyclosporine and fluconazole in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction of cyclosporin and itraconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Levofloxacin does not alter cyclosporine disposition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Concurrent clarithromycin and cyclosporin A treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Acute heart transplant rejection due to Saint John's wort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Drug interaction between St. John's wort and cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Drug interaction of St John's wort with cyclosporin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Unexplained decrease of cyclosporin trough levels in a compliant renal transplant patient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Rifampin-fluconazole interaction in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Effect of fluconazole on the disposition of phenytoin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Fluconazole-warfarin interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Vincristine toxicity in five children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Itraconazole greatly increases plasma concentrations and effects of felodipine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Possible interaction between phenobarbital, carbamazepine and itraconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Interaction of itraconazole and digoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Itraconazole-Digoxin Interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Digoxin toxicity associated with itraconazole therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Effect of itraconazole on the pharmacokinetics of atorvastatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Effect of rifampicin on the pharmacokinetics of itraconazole in normal volunteers and AIDS patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Disposition of intravenous and oral cyclosporine after administration with grapefruit juice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Effect of grapefruit juice on blood cyclosporin concentration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704316

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704316

1 reference

9 August 2017

1 reference